Drug Half-Life from Two Concentrations: Clinical Guide

Overview

Calculates first-order elimination half-life from two post-distribution concentrations and sample times.

Clinical Significance

The estimate assumes post-distribution first-order decline. It is frequently used in therapeutic drug monitoring but requires exact sampling and dosing history.

When to Use

• Estimate half-life from two valid concentrations on the elimination phase.
• Use exact collection times.
• Confirm stable renal function and no intervening dose.

How It Is Calculated

• First calculate k = ln(C1/C2) ÷ Δt, then half-life = ln(2) ÷ k.
• The calculator validates the required inputs before applying the equation and rounds only the displayed result.

Interpretation

• The estimate assumes post-distribution first-order decline. It is frequently used in therapeutic drug monitoring but requires exact sampling and dosing history.
• Review the component values and assumptions as well as the final result.

Worked Example

Enter clinically plausible values in the stated units. MedicalC applies: First calculate k = ln(C1/C2) ÷ Δt, then half-life = ln(2) ÷ k. Review the displayed result against the source data and the relevant clinical pathway.

Patient Considerations

• Confirm that the patient and clinical setting match the population or physiologic assumptions behind the equation.
• Consider whether treatment, organ function, pregnancy, body composition, sampling conditions or acute illness materially alter interpretation.
• Use serial calculations only when methods and units remain comparable.

Limitations

• Distribution-phase sampling overestimates elimination.
• Changing kidney function or dialysis invalidates the estimate.
• Two concentrations do not prove one-compartment behaviour.

Clinical Pearls

• Review the concentration-time plot when more samples are available.
• Use the same time unit throughout.
• Recalculate after a material change in clearance.

Common Mistakes

• Using scheduled rather than actual sample times.
• Including a concentration drawn during infusion or distribution.
• Ignoring an additional dose between samples.

Evidence Base

The implementation uses the published or established relationship: First calculate k = ln(C1/C2) ÷ Δt, then half-life = ln(2) ÷ k. The cited source should be reviewed alongside current specialty guidance before clinical deployment.

References

1. Sawchuk RJ, Zaske DE. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions. J Pharmacokinet Biopharm. 1976. — Primary publication, authoritative guideline or recognised clinical source supporting the calculation.